Go Pro
CVE:SVS

Solarvest BioEnergy (SVS) Stock Price, News & Analysis

Solarvest BioEnergy logo
C$0.02 0.00 (0.00%)
As of 09/5/2023

About Solarvest BioEnergy Stock (CVE:SVS)

Key Stats

Today's Range
C$0.02
C$0.03
50-Day Range
C$0.03
C$0.03
52-Week Range
C$0.01
C$0.14
Volume
3,159 shs
Average Volume
77,594 shs
Market Capitalization
C$1.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Solarvest BioEnergy and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SVS Stock News Headlines

TSM just handed Trump's secretive AI project $100 billion
Taiwan Semiconductor just committed another $100 billion to U.S. chip manufacturing - on top of $165 billion already pledged. Louis Navellier, who manages a $1.1 billion portfolio including $358 million in AI stocks, says this isn't about tariffs. Navellier believes TSM's move is smart money positioning ahead of a government AI supercomputing project he calls Golden Dawn - built at the same Tennessee site that housed the Manhattan Project. S&P 500 profits are tracking near 24% growth this quarter, with AI and chip demand leading the way.tc pixel
See More Headlines

SVS Stock Analysis - Frequently Asked Questions

Solarvest BioEnergy's stock was trading at C$0.03 at the start of the year. Since then, SVS stock has increased by 0.0% and is now trading at C$0.03.

Shares of SVS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Solarvest BioEnergy investors own include FSD Pharma (HUGE), Intercept Pharmaceuticals (ICPT), Sernova (SVA), Routemaster Capital Inc. (RM.V) (RM), IGEN Networks (IGEN) and Clean Energy Pathways (CPWY).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:SVS
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$2.26 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-143.12%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
0.02

Sales & Book Value

Annual Sales
C$740.00
Price / Sales
2,052.70
Cash Flow
C$0.00 per share
Price / Cash Flow
55.00
Book Value
C($0.10) per share
Price / Book
-0.25

Miscellaneous

Outstanding Shares
60,760,000
Free Float
N/A
Market Cap
C$1.52 million
Optionable
Not Optionable
Beta
1.50
10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (CVE:SVS) was last updated on 7/22/2026 by MarketBeat.com Staff.
From Our Partners